Bayer Healthcare Phamaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Bayer Healthcare Phamaceuticals, Inc.

Sort by

Viewing results 1‒25 of 90

Drug prices
US drugmakers withdraw from NHS pricing agreement as costs soar
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
January 16, 2023
News in-depthRoyal Philips NV
Philips device recall leaves sleep apnoea sufferers in distress
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
August 27, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Coronavirus
US hospitals panic-buy drugs ahead of coronavirus influx
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
March 21, 2020
Mergers & Acquisitions
JPMorgan Chase set to scoop record fee for Allergan sale
...Bayer, for instance, has struggled since digesting its Monsanto purchase, with its market value falling by more than $45bn since the deal.....
August 13, 2019
Due Diligence
Media M&A: Ain’t No Business Like Show Business Premium content
...His hedge fund Elliott Management has disclosed a stake in the software company SAP, the troubled healthcare and agriculture conglomerate Bayer and the online classifieds group Scout24, this year alone....
August 9, 2019
News in-depthThe Big Read
The Apple effect: Germany fears being left behind by Big Tech
...software company valued at $2.5bn, says he has spent a lot of time trying to figure out why Germany has lost the spirit of the Gründerzeit — the “founding epoch” in the late 19th century when Daimler, Bayer...
January 29, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthThe Big Read
J&J: The next target of anger over America’s opioid crisis?
...It was this statement of corporate social responsibility — crafted decades before the term became overused PR — which he said had guided the world’s largest healthcare company to become a solid, long-term...
September 5, 2019
Due Diligence
Has T-Mobile done enough to save its Sprint deal? Premium content
...The 62-year old, who’s a supervisory board member at Bayer, witnessed the unprecedented vote of no confidence that investors delivered to the company last month....
May 21, 2019
Markets InsightOlaf Storbeck
Germany’s demerger mania requires tougher scrutiny
...Two years later, the share price of Covestro, the plastics unit of German chemicals company Bayer, doubled within its first year as an independent company, trouncing Bayer’s performance....
December 7, 2018
GSK PLC
GlaxoSmithKline to break up after striking Pfizer joint venture
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
December 19, 2018
News in-depthUS & Canadian companies
GSK’s move for Pfizer’s consumer arm divides market
...Reckitt cited financial discipline for quitting the two-horse race, as it also did in 2014, when it withdrew from bidding for the healthcare unit of Merck of the US, leaving Germany’s Bayer to clinch the...
March 22, 2018
LexUS & Canadian companies
Pfizer: shelf medication Premium content
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
October 10, 2017
US & Canadian companies
Pfizer weighs sale of consumer health business
...Nestlé, the Swiss foods group, has said that it is in the market for such assets, while analysts also cite drugmakers such as GlaxoSmithKline, Bayer, Sanofi and Johnson & Johnson as potential buyers....
October 10, 2017
Asia-Pacific equities
Japan’s cutting edge dulled by desire to remain in control
...By acquiring Bayer’s diabetes care business in early 2016 and combining it with the Panasonic division, the new owner was able to double revenues....
July 26, 2017
News in-depthThe Big Read
Drug prices: Tweaking the formula
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
April 25, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
Medivation agrees to $10bn takeover talks
...The former Pfizer and Bayer executive has made dealmaking a key pillar of his strategy to strengthen the pharmaceutical company since taking over last year....
July 5, 2016
LexPharmaceuticals sector
Sanofi/Boehringer: swap shop
...It allows Sanofi to bulk up in consumer healthcare, creating a business with annual revenue of more than €5bn....
December 15, 2015
News in-depthUS & Canadian companies
Investor calls for big pharma to slim down grow louder
...Novartis (animal health and vaccines), Bayer (plastics), Sanofi (animal health) and Pfizer (animal health) have relinquished unwanted businesses or are in the process of doing so....
February 1, 2016
Currencies
Weak euro lifts European drugmakers
...Consumer healthcare was among Bayer’s strongest sources of growth after its $14bn acquisition of over-the-counter medicines from Merck of the US last year....
April 30, 2015
UK companies
Pharma groups eye healthy returns from animal drugs market
...Jeffrey Holford, analyst at Jefferies, has touted Bayer as another “logical and motivated” potential acquirer....
July 1, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...“Healthcare has been like a cottage industry but that is beginning to change.”...
April 26, 2015
US & Canadian companies
Ackman’s Pershing Square secures seat on Zoetis board
...Bayer and Novartis both expressed interest in buying Zoetis before it was carved out of Pfizer, but the rules governing spin-offs made it difficult for them to acquire it during the two years after it became...
February 4, 2015
US & Canadian companies
Shire Pharmaceuticals eyes the big league with Baxalta bid
...Shire revealed it had approached Baxalta in early July, one day after the Illinois-based company had completed its spin-off from Baxter, the bigger US healthcare group....
August 4, 2015
European companies
Sanofi appoints Brandicourt as CEO
...Dr Brandicourt is a Paris-educated medic who rose through the ranks of Pfizer before taking charge of Bayer’s healthcare division in 2013....
February 19, 2015
US & Canadian companies
AbbVie joins the pharma chain reaction
...This greater willingness to make clear choices about strategic priorities has been evident in deals such as Bayer’s $14.2bn acquisition of Merck’s consumer healthcare division last year — a transaction that...
March 6, 2015

Previous pagePage 1 of 4Next page